Lyell Wealth Management, LP Pfizer Inc Transaction History

Lyell Wealth Management, LP

$1.09 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $3,762 - $4,887	144 Added 1.87%	7,853 $226,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $56,959 - $66,580	-1,775 Reduced 18.72%	7,709 $255,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $36 - $41	-1 Reduced 0.01%	9,484 $347,000
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $26,942 - $35,075	-684 Reduced 6.73%	9,485 $386,000
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $62,249 - $81,259	1,491 Added 17.18%	10,169 $0
Q3 2022 Oct 24, 2022	SELL	$43.76 - $53.42 $68,703 - $83,869	-1,570 Reduced 15.32%	8,678 $380,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $38,154 - $45,239	820 Added 8.7%	10,248 $537,000
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $72,056 - $89,286	1,575 Added 20.06%	9,428 $488,000
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $9,503 - $14,087	-230 Reduced 2.85%	7,853 $464,000
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $68,687 - $88,235	-1,750 Reduced 17.8%	8,083 $348,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $42,194 - $47,799	1,175 Added 13.57%	9,833 $385,000
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $89,753 - $101,223	-2,680 Reduced 23.64%	8,658 $314,000
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $181,139 - $230,334	5,412 Added 91.33%	11,338 $417,000
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $188,150 - $220,743	5,926 New	5,926 $217,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $177,100 - $253,038	-6,552 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $32,031 - $36,351	973 Added 17.44%	6,552 $257,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $579,426 - $751,346	-17,834 Reduced 76.17%	5,579 $200,000
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $737,935 - $828,531	-19,955 Reduced 46.01%	23,413 $1.01 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $1.91 Million - $2.1 Million	-51,038 Reduced 54.06%	43,368 $1.84 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $46,933 - $53,509	1,220 Added 1.31%	94,406 $4.12 Million
Q3 2018 Oct 30, 2018	BUY	$34.47 - $41.81 $64,631 - $78,393	1,875 Added 2.05%	93,186 $4.11 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $18,798 - $20,041	-570 Reduced 0.62%	91,311 $3.31 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $152,976 - $177,473	4,794 Added 5.5%	91,881 $3.26 Million
Q4 2017 Jan 30, 2018	BUY	$33.26 - $35.29 $32,428 - $34,407	975 Added 1.13%	87,087 $3.15 Million
Q3 2017 Oct 26, 2017	BUY	$31.0 - $34.15 $2.67 Million - $2.94 Million	86,112	86,112 $3.07 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.52 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.

Account